Bruce J. Shook
President and CEO
Mr. Bruce Shook is a highly-experienced, medical device executive with more than 30 years of industry experience, including multiple early stage ventures focused on opportunities in cardiac surgery, cardiology, neurosurgery, psychiatry and vascular disease. Mr. Shook formed Vesper Medical in 2016 as a spinout of Intact Vascular. He serves as Director, President and CEO for both companies. Prior to Vesper Medical and Intact Vascular, Mr. Shook was co-founder, Director, President and CEO of Neuronetics, Inc., which is a privately held medical device company that markets a non-invasive brain stimulation technology for the treatment of depression.
Previously, Mr. Shook was co-founder, Director, President and CEO at Neuron Therapeutics, a venture-backed company developing a drug/device product for the treatment of CNS disorders and President of Abiomed [NASDAQ: ABMD] where he successfully obtained PMA approval for the first, FDA-approved ventricular assist device. Mr. Shook also developed cardiac pacing and anti-arrhythmia products at Cordis Corporation.
Mr. Shook holds advanced degrees in Biomedical Engineering and Business Administration from Columbia University and the MIT Sloan School of Management, respectively. He earned a B.S. degree in Chemical Engineering from Penn State University. Mr. Shook currently serves on the Board of Directors at Venarum Medical, the Penn State Research Foundation and the Pennsylvania Biotechnology Association. He previously served as a Director at Surgiquest, Respicardia and CoTherix.